Phoenix Biotech Acquisition Corp. announced the pricing of its $155 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “PBAXU” Wednesday, October 6.
The Company intends to combine with a life sciences business that addresses unmet medical and commercial needs and offers unrecognized value within the investment community. Phoenix Biotech is led by CEO Chris Ehrlich, CFO Daniel Geffken, and President Douglas Fisher.
Total SPAC deal count for 2021 year-to-date is now 453. This offering is expected to close on Friday, October 8.
Cantor Fitzgerald & Co. is serving as sole book-running manager for the offering. Ledgewood, PC is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Citrin Cooperman & Company, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
At the SPAC of Dawn Lately de-SPACs have been announcing corporate moves of a kind frequently in trios as was the case earlier this week when WeBull (NASDAQ:BULL), AST SpaceMobile (NASDAQ:ASTS) and Quantum-Si (NASDAQ:QSI) all announced major equity raises. This week, it is a trio of de-SPACs making reverse stock splits in unison, which is...
A look at Plus’ software-first approach to autonomous trucking. After years of investment and excitement, the dawn of self-driving cars and trucks is now here. The question now is which business model among autonomous driving technology companies will win out? This week, we speak with David Liu, CEO of autonomous trucking company Plus. Plus announced...
At the SPAC of Dawn One thing that SPAC investors can typically count on while their money is invested in a SPAC’s trust is that it is going to grow one way or the other between now and their next redemption opportunity, but the devil can occasionally be in the details. In 2024, it became...
Thunderstone has filed for a $50 million SPAC to put a new first-time Asia-based team in action on a generalist hunt. The new SPAC is offering investors a right to a 1/8 share in each unit with 18 months to initially complete a business combination. It is the 8th fresh S-1 filed with underwriter D....
At the SPAC of Dawn In a trading session that may find itself built around the release of Fed minutes at 2 pm ET this afternoon, a pair of SPAC targets have added their own fresh information to the mix. Enterprise AI firm Fusemachines, which has a pending combination with CSLM (OTC:CSLMF), put out a...